Journal of Neurology

, Volume 255, Issue 6, pp 820–827 | Cite as

Rehabilitation in primary and metastatic brain tumours

Impact of functional outcomes on survival
  • V. Tang
  • M. Rathbone
  • J. Park Dorsay
  • S. Jiang
  • D. Harvey
ORIGINAL COMMUNICATION

Abstract

Objectives

Patientswith brain tumours have majordisabilities and guarded prognosisbut may benefit from inpatient rehabilitation.The objectives were tocompare functional outcomes inpatients with glioblastoma multiforme(GBM), brain metastasesand other brain tumours, and todetermine predictors of survival.

Methods

Demographic, clinical,functional, and survival data werecollected for 63 patients.Kaplan-Meier and Cox regression wereused for survival analyses.

Results

Functional Independence Measure(FIM™) scores improved fromadmission to discharge for patientswith GBM, brain metastases andother tumours. Estimated mediansurvival was 141 days for brainmetastases, 214 days for GBM and439 days for other tumours. Lowadmission dexamethasone doseand high FIM™ gain predictedbetter survival in GBM. For brainmetastases, high FIM™ gain, lowdexamethasone dose and no organmetastases were positive prognosticfactors.

Conclusions

Patientswith primary and metastatic braintumours achieved functional gainsafter rehabilitation. High functionalimprovement is a significantpredictor of longer survival inbrain metastases and GBM. Thisstudy has implications for rehabilitationin the post-acute managementof patients who have disabilitiesdue to brain tumours.

Key words

functionalindependence measure neurorehabilitation prognosis brain tumour metastasis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Cancer Society (2006)Cancer Facts and Figures 2006. Atlanta:American Cancer SocietyGoogle Scholar
  2. 2.
    DeLisa JA (2001) A history of cancerrehabilitation. Cancer 92:970–974PubMedCrossRefGoogle Scholar
  3. 3.
    Lehmann JF, DeLisa JA, Warren CG,deLateur BJ, Bryant PL, Nicholson CG(1978) Cancer rehabilitation: Assessmentof need, development, and evaluationof a model of care. Arch PhysMed Rehabil 59:410–419Google Scholar
  4. 4.
    Harvey RF, Jellinek HM, Habeck RV(1982) Cancer rehabilitation: An analysisof 36 program approaches. JAMA247:2127–2131PubMedCrossRefGoogle Scholar
  5. 5.
    Boake C, Meyers CA (1993) Braintumor rehabilitation: Survey of clinicalpractice. Arch Phys Med Rehabil 74:1247 (abstract)CrossRefGoogle Scholar
  6. 6.
    Kirshblum S, O’Dell MW, Ho C, Barr K(2001) Rehabilitation of persons withcentral nervous system tumors. Cancer92:1029–1038PubMedCrossRefGoogle Scholar
  7. 7.
    Huang ME, Cifu DX, Keyser-Marcus L(2000) Functional outcomes in patientswith brain tumor after inpatientrehabilitation: Comparison with traumaticbrain injury. Am J Phys MedRehabil 79:327–335CrossRefGoogle Scholar
  8. 8.
    Huang ME, Cifu DX, Keyser-Marcus L(1998) Functional outcome after braintumor and acute stroke: A comparativeanalysis. Arch Phys Med Rehabil 79:1386–1390PubMedCrossRefGoogle Scholar
  9. 9.
    O’Dell MW, Barr K, Spanier D, WarnickRE (1998) Functional outcome of inpatientrehabilitation in persons withbrain tumors. Arch Phys Med Rehabil79:1530–1534PubMedCrossRefGoogle Scholar
  10. 10.
    Greenberg E, Treger I, Ring H (2006)Rehabilitation outcomes in patientswith brain tumors and acute stroke:Comparative study of inpatient rehabilitation.Am J Phys Med Rehabil85:568–573PubMedCrossRefGoogle Scholar
  11. 11.
    Sherer M, Meyers CA, Bergloff P (1997)Efficacy of postacute brain injury rehabilitationfor patients with primarymalignant brain tumors. Cancer 80:250–257PubMedCrossRefGoogle Scholar
  12. 12.
    Huang ME, Wartella JE, Kreutzer JS(2001) Functional outcomes and qualityof life in patients with brain tumors:A preliminary report. Arch PhysMed Rehabil 82:1540–1546CrossRefGoogle Scholar
  13. 13.
    Marciniak CM, Sliwa JA, HeinemannAW, Semik PE (2001) Functional outcomesof persons with brain tumorsafter inpatient rehabilitation. ArchPhys Med Rehabil 82:457–463CrossRefGoogle Scholar
  14. 14.
    Mukand JA, Blackinton DD, CrincoliMG, Lee JJ, Santos BB (2001) Incidenceof neurologic deficits and rehabilitationof patients with brain tumors. AmJ Phys Med Rehabil 80:346–350CrossRefGoogle Scholar
  15. 15.
    Lagerwaard FJ, Levendag PC, NowakPJ, Eijkenboom WM, Hanssens PE,Schmitz PI (1999) Identification ofprognostic factors in patients withbrain metastases: A review of 1292patients. Int J Radiat Oncol Biol Phys43:795–803PubMedGoogle Scholar
  16. 16.
    Korinth MC, Delonge C, Hutter BO,Gilsbach JM (2002) Prognostic factorsfor patients with microsurgically resectedbrain metastases. Onkologie25:420–425PubMedCrossRefGoogle Scholar
  17. 17.
    Broadbent AM, Hruby G, Tin MM,Jackson M, Firth I (2004) Survivalfollowing whole brain radiation treatmentfor cerebral metastases: An auditof 474 patients. Radiother Oncol 71:259–265PubMedCrossRefGoogle Scholar
  18. 18.
    CBTRUS (Central Brain TumorRegistry of the United States) (2005)Statistical report: Primary brain tumorsin the United States, 1998–2002.Chicago: Central Brain Tumor Registryof the United StatesGoogle Scholar
  19. 19.
    Sathornsumetee S, Rich JN (2006) Newtreatment strategies for malignantgliomas. Expert Rev Anticancer Ther6:1087–1104PubMedCrossRefGoogle Scholar
  20. 20.
    Wrensch M, Fisher JL, SchwartzbaumJA, Bondy M, Berger M, Aldape KD(2005) The molecular epidemiology ofgliomas in adults. Neurosurg Focus19:E5PubMedCrossRefGoogle Scholar
  21. 21.
    Giannini C, Scheithauer BW, WeaverAL, Burger PC, Kros JM, Mork S, GraeberMB, Bauserman S, Buckner JC,Burton J, Riepe R, Tazelaar HD, NascimentoAG, Crotty T, Keeney GL, PerniconeP, Altermatt H (2001) Oligodendrogliomas:Reproducibility andprognostic value of histologic diagnosisand grading. J Neuropathol ExpNeurol 60:248–262Google Scholar
  22. 22.
    Milstein JM, Cohen ME, Sinks LF(1985) The influence and reliability ofneurologic assessment and Karnofskyperformance score on prognosis.Cancer 56:1834–1836PubMedCrossRefGoogle Scholar
  23. 23.
    Stern JI, Raizer JJ (2006) Chemotherapyin the treatment of malignantgliomas. Expert Rev Anticancer Ther6:755–767PubMedCrossRefGoogle Scholar
  24. 24.
    Brazil L, Thomas R, Laing R, Hines F,Guerrero D, Ashley S, Brada M (1997)Verbally administered Barthel Index asfunctional assessment in brain tumourpatients. J Neurooncol 34:187–192PubMedCrossRefGoogle Scholar
  25. 25.
    Meyers CA, Hess KR, Yung WK, LevinVA (2000) Cognitive function as a predictorof survival in patients with recurrentmalignant glioma. J Clin Oncol18:646–650PubMedGoogle Scholar
  26. 26.
    Keith RA, Granger CV, Hamilton BB,Sherwin FS (1987) The functional independencemeasure: A new tool forrehabilitation. Adv Clin Rehabil 1:6–18PubMedGoogle Scholar
  27. 27.
    Barber MD, Ross JA, Fearon KC (1999)Cancer cachexia. Surg Oncol 8:133–141PubMedCrossRefGoogle Scholar
  28. 28.
    Viale PH (2005) Abnormal clotting incancer: An overview of pathophysiologyand etiology. Semin Oncol Nurs21:12–20PubMedCrossRefGoogle Scholar
  29. 29.
    Davis, MP, Khoshknabi D, Yue GH(2006) Management of fatigue incancer patients. Curr Pain HeadacheRep 10:260–269CrossRefGoogle Scholar
  30. 30.
    O’Dell MW (1999) Neurorehabilitationin cancer: Brain tumors. RehabilitationOncology 17:32–33Google Scholar
  31. 31.
    Rubin EH, Hait WN (2003) Principlesof cancer treatment. In: ACP MedicineOncology (online). Available at:www.acpmedicine.com. AccessedNovember 6:2006Google Scholar
  32. 32.
    Vecht CJ, Hovestadt A, Verbiest HB, vanVliet JJ, van Putten WL (1994) Doseeffectrelationship of dexamethasoneon Karnofsky performance in metastaticbrain tumors: A randomized studyof doses of 4,8, and 16 mg per day.Neurology 44:675–680PubMedGoogle Scholar
  33. 33.
    Hempen C, Weiss E, Hess CF (2002)Dexamethasone treatment in patientswith brain metastases and primarybrain tumors: Do the benefits outweighthe side-effects? Support CareCancer 10:322–328CrossRefGoogle Scholar
  34. 34.
    Crevenna R, Schmidinger M, KeilaniM, Nuhr M, Fialka-Moser V, Zettinig G,Quittan M (2003) Aerobic exercise fora patient suffering from metastaticbone disease. Support Care Cancer11:120–122PubMedGoogle Scholar
  35. 35.
    Crevenna R, Fialka-Moser V, Keilani M,Schmidinger M, Marosi C, Quittan M(2002) Aerobic physical training in abreast cancer patient with inflammatoryrecurrence. Wien Med Wochenschr152:581–584PubMedCrossRefGoogle Scholar
  36. 36.
    Crevenna R, Schmidinger M, KeilaniM, Nuhr M, Nur H, Zoch C, Zielinski C,Fialka-Moser V, Quittan M (2003)Aerobic exercise as additive palliativetreatment for a patient with advancedhepatocellular cancer. Wien MedWochenschr 153:237–240CrossRefGoogle Scholar
  37. 37.
    Oldervoll LM, Loge JH, Paltiel H, AspMB, Vidvei U, Wiken AN, HjermstadMJ, Kaasa S (2006) The effect of aphysical exercise program in palliativecare: A phase II study. J Pain SymptomManage 31:421–430CrossRefGoogle Scholar
  38. 38.
    Headley JA, Ownby KK, John LD(2004) The effect of seated exercise onfatigue and quality of life in womenwith advanced breast cancer. OncolNurs Forum 31:977–983CrossRefGoogle Scholar
  39. 39.
    Davis JM, Kohut ML, Jackson DA,Colbert LH, Mayer EP, Ghaffar A(1998) Exercise effects on lung tumormetastases and in vitro alveolarmacrophage antitumor cytotoxicity.Am J Physiol 274:R1454–R1459PubMedGoogle Scholar
  40. 40.
    Fairey AS, Courneya KS, Field CJ, BellGJ, Jones LW, Mackey JR (2005) Randomizedcontrolled trial of exerciseand blood immune function in postmenopausalbreast cancer survivors.J Appl Physiol 98:1534–1540PubMedCrossRefGoogle Scholar
  41. 41.
    Jadeski L, Hoffman-Goetz L (1996) Exerciseand in vivo natural cytotoxicityagainst tumour cells of varyingmetastatic capacity. Clin Exp Metastasis14:138–144PubMedCrossRefGoogle Scholar
  42. 42.
    MacNeil B, Hoffman-Goetz L (1993)Effect of exercise on natural cytotoxicityand pulmonary tumour metastasesin mice. Med Sci Sports Exerc 25:922–928PubMedGoogle Scholar
  43. 43.
    Murphy EA, Davis JM, Brown AS,Carmichael MD, Mayer EP, Ghaffar A(2004) Effects of moderate exerciseand oat beta-glucan on lung tumormetastases and macrophage antitumorcytotoxicity. J Appl Physiol 97:955–959PubMedCrossRefGoogle Scholar
  44. 44.
    Jones LW, Guill B, Keir ST, Carter BS,Friedman HS, Bigner DD, Reardon DA(2006) Patterns of exercise across thecancer trajectory in brain tumor patients.Cancer 106:2224–2232PubMedCrossRefGoogle Scholar
  45. 45.
    Davidoff GN, Roth EJ, Haughton JS,Ardner MS (1990) Cognitive dysfunctionin spinal cord injury patients:sensitivity of the Functional IndependenceMeasure subscales vs neuropsychologicassessment. Arch Phys MedRehabil 71:326–329Google Scholar
  46. 46.
    Corrigan JD, Smith-Knapp K, GrangerCV (1997) Validity of the functionalindependence measure for personswith traumatic brain injury. Arch PhysMed Rehabil 78:828–834CrossRefGoogle Scholar

Copyright information

© Steinkopff-Verlag 2008

Authors and Affiliations

  • V. Tang
    • 1
  • M. Rathbone
    • 1
  • J. Park Dorsay
    • 4
  • S. Jiang
    • 3
  • D. Harvey
    • 2
  1. 1.Division of NeurologyMcMaster UniversityHamiltonCanada
  2. 2.Division of Physical Medicine andRehabilitationMcMaster University,Henderson General HospitalHamiltonCanada L8V 1C
  3. 3.Division of NeurosurgeryMcMaster UniversityHamiltonCanada
  4. 4.Hamilton Health SciencesHamiltonCanada

Personalised recommendations